Koppers Holdings KOP Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number at other companies

AMN HealthcareAMN

304K+29.9%

RepligenRGEN

116.8K—

The Baldwin Insurance Group, Inc.BWIN

1.7M+57.1%

Mondelez InternationalMDLZ

6.6M+14.8%

RepligenRGEN

567K—

Cal-Maine FoodsCALM

529-74.3%

Other financials

Income statement

See full

Revenue$455.3M-0.3%

Gross profit$86.6M-18.1%

Operating income$22.0M-18.5%

Net income$7.1M+151%

EPS (diluted)$0.35+151%

Balance sheet

See full

Cash & equivalents$42.8M+28.5%

Total debt$1.0B-4.3%

Total equity$549.5M+10.3%

Total assets$1.9B-0.6%

Cash flow

See full

Operating cash flow$46.3M+304%

CapEx$11.4M-20.3%

Free cash flow$34.9M+194%

Valuation

See full

Market cap$859.66M+37.3%

Enterprise value$1.84B+10.7%

P/E11.2×—

P/S0.5×+0.2×

Profitability

See full

Gross margin22.8%+1.7pp

Operating margin8.7%+1.8pp

Net margin4.1%—

FCF margin7.4%—

Returns & leverage

See full

Return on equity14.7%—

Debt / equity1.9×-0.3×

Current ratio2.7×+0.1×

Where this comes from

Reported directly by Koppers Holdings in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.

The official record: Koppers Holdings’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Koppers Holdings's share based compensation arrangement by share based payment award equity instruments other than options nonvested number.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Koppers Holdings's share based compensation arrangement by share based payment award equity instruments other than options nonvested number?: Koppers Holdings (KOP) reported share based compensation arrangement by share based payment award equity instruments other than options nonvested number of $1.2M in Q1 2026.